Form 4 for REGN Regeneron Pharmaceuticals
Accepted 2021-08-10 00:00:00 ET · period of report 2021-08-09 · accession 0001237899-21-000012 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2021-08-10 | 2021-08-09 | REGN | BROWN MICHAEL S | Dir | S - Sale | $612.38 | -1,687 | 7,662 | -18% | -$1.03M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-09 | S | D | 1,687 | $612.38 | 7,662 | I by Trust | — | — |